JP Morgan Chase
BVS icon

JP Morgan Chase’s Bioventus BVS Stock Holding History

JP Morgan Chase’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
149,615
+51,120
+52% +$488K ﹤0.01% 4418
2026
Q1 		$883K Sell
98,495
-11,595
-11% -$97.2K ﹤0.01% 4685
2025
Q4 		$819K Sell
110,090
-4,687
-4% -$33.7K ﹤0.01% 4732
2025
Q3 		$768K Sell
114,777
-128,933
-53% -$895K ﹤0.01% 4770
2025
Q2 		$1.61M Sell
243,710
-39,433
-14% -$280K ﹤0.01% 4071
2025
Q1 		$2.59M Sell
283,143
-15,987
-5% -$160K ﹤0.01% 3676
2024
Q4 		$3.14M Buy
299,130
+45,390
+18% +$537K ﹤0.01% 3802
2024
Q3 		$3.03M Buy
253,740
+176,442
+228% +$1.53M ﹤0.01% 3633
2024
Q2 		$444K Sell
77,298
-29,208
-27% -$160K ﹤0.01% 4750
2024
Q1 		$554K Buy
106,506
+49,697
+87% +$243K ﹤0.01% 4734
2023
Q4 		$299K Buy
56,809
+56,534
+20,558% +$224K ﹤0.01% 5108
2023
Q3 		$908 Sell
275
-1,504
-85% -$5.28K ﹤0.01% 6659
2023
Q2 		$5.14K Sell
1,779
-104,479
-98% -$201K ﹤0.01% 6167
2023
Q1 		$114K Sell
106,258
-235,442
-69% -$450K ﹤0.01% 5366
2022
Q4 		$892K Sell
341,700
-10,728
-3% -$46.8K ﹤0.01% 4131
2022
Q3 		$2.47M Sell
352,428
-9,355
-3% -$73.3K ﹤0.01% 3305
2022
Q2 		$2.47M Sell
361,783
-852
-0.2% -$8.69K ﹤0.01% 3371
2022
Q1 		$5.11M Sell
362,635
-40,458
-10% -$542K ﹤0.01% 2984
2021
Q4 		$5.84M Buy
403,093
+35,617
+10% +$506K ﹤0.01% 2932
2021
Q3 		$5.2M Sell
367,476
-16,976
-4% -$261K ﹤0.01% 2994
2021
Q2 		$6.77M Buy
384,452
+362,855
+1,680% +$5.85M ﹤0.01% 2779
2021
Q1 		$330K Buy
+21,597
New +$308K ﹤0.01% 4916

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase's BVS Position: Q2 2026 in Review

JP Morgan Chase increased its Bioventus (BVS) stake by 52% in Q2 2026, buying an estimated $488K and bringing the position to 149,615 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4418.

JP Morgan Chase first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.77M in Q2 2021. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • JP Morgan Chase held 149,615 shares of Bioventus worth $1.46M as of Q2 2026.
  • JP Morgan Chase bought 51,120 Bioventus shares in Q2 2026, an estimated $488K.
  • Bioventus made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4418 holding.
  • JP Morgan Chase first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
  • JP Morgan Chase's Bioventus position peaked at $6.77M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.